Resveratrol and Some of Its Derivatives as Promising Prophylactic Treatments for Neonatal Hypoxia-Ischemia

Nutrients. 2022 Sep 14;14(18):3793. doi: 10.3390/nu14183793.

Abstract

Due to the rate of occurrence of neonatal hypoxia-ischemia, its neuronal sequelae, and the lack of effective therapies, the development of new neuroprotective strategies is required. Polyphenols (including resveratrol) are molecules whose anti-apoptotic, anti-inflammatory, and anti-oxidative properties could be effective against the damage induced by neonatal hypoxia-ischemia. In this review article, very recent data concerning the neuroprotective role of polyphenols and the mechanisms at play are detailed, including a boost in brain energy metabolism. The results obtained with innovative approaches, such as maternal supplementation at nutritional doses, suggest that polyphenols could be a promising prophylactic treatment for neonatal hypoxia-ischemia.

Keywords: neonatal hypoxia-ischemia; neuroprotection; polyphenols.

Publication types

  • Review

MeSH terms

  • Animals
  • Animals, Newborn
  • Hypoxia-Ischemia, Brain* / complications
  • Hypoxia-Ischemia, Brain* / drug therapy
  • Hypoxia-Ischemia, Brain* / prevention & control
  • Ischemia / complications
  • Ischemia / drug therapy
  • Neuroprotective Agents* / pharmacology
  • Neuroprotective Agents* / therapeutic use
  • Polyphenols / therapeutic use
  • Resveratrol / pharmacology
  • Resveratrol / therapeutic use

Substances

  • Neuroprotective Agents
  • Polyphenols
  • Resveratrol